Approximately 35.6 million people are followed up with the diagnosis of dementia across the world. The incidence of dementia has increased along with the prolongation of human life span, and it is a challenging process for the affected people and their relatives and a significant financial burden for the economies of countries (1). Alzheimer-type dementia, which is the most common cause of dementia, constitutes 50%-70% of all dementia cases (2).There is still no treatment modality that could alter the pathological and clinical course of Alzheimer's disease (AD), and numerous studies are ongoing in this regard. In recent years, there has been a belief that the diagnosis of Alzheimer-type dementia can be made before the manifestation of clinical findings and that this approach may allow application of possible new treatments in the early period (3).Mild cognitive impairment (MCI) implies a transition state between normal cognitive functions and Alzheimer-type dementia. MCI is characterized by cognitive loss, absence of impairment in daily activities, and absence of dementia according to age and education norms which are also confirmed by the relatives of the patients. Studies have shown that MCI can be used to identify individuals with high risk in terms of the progression to Alzheimer-type dementia (4). Alzheimertype dementia has been reported to develop in 10%-40% of patients within 1 year following the diagnosis of MCI (5).The diagnosis of MCI is made through clinical evaluation, imaging modalities, and neuropsychometric tests. The Montreal Cognitive Assessment (MoCA) scale is a test that has been used in recent years to assess cognitive features such as attention and concentration, executive functions, memory, language, visual-spatial functions, abstract thinking, calculation, and orientation. The scale has been developed by Nasreddine et al. (6) and is recommended for use in the mild stages of cognitive impairment. Several features in the design of the MoCA test allow it to detect MCI with greater sensitivity. In MCI, executive functions, high language functions, and complex visualspatial functions are moderately affected. This moderate decrease can be demonstrated by the Methods: This study included 25 healthy controls and 25 patients diagnosed with MCI according to the Petersen criteria. Detailed neurological examination was performed. MoCA and Standardized Mini Mental State Examination (MMSE) were used in the patient group, whereas MMSE was used in all participants. To all exhibitors cranial magnetic resonance imaging was performed. Right and left hippocampal volumes were calculated using special volumetric three-dimentional T1-weighted inversion recovery sequence. Neuropsychological test results and hippocampal volumes were compared between the patient and control groups.Results: There were significant differences in hippocampal volumes and MMSE scores between the HBB patient and control groups (p<0.001, p=0.011, p=0.014). We found a significant relationship between MoCA average test score and left hippo...